Search research articles
Contact Us
Filters
Showing results (51-60 of 80) with videos related to
Page
of 8
Sort By:
Brain Sciences
|
July 27, 2024
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life Study
Piero Barbanti, Bianca Orlando, Gabriella Egeo, et al.
The Journal of Headache and Pain
|
April 13, 2026
Breaking the medication overuse headache cycle: from nociplastic pain mechanisms to patient-centered interventions - the Junior Editorial Board vision
Roberta Messina, Matteo Castaldo, Woo-Seok Ha, et al.
The Journal of Headache and Pain
|
December 13, 2023
Health equity, care access and quality in headache - part 2
Bianca Raffaelli, Eloísa Rubio-Beltrán, Soo-Jin Cho, et al.
Cephalalgia : an International Journal of Headache
|
June 6, 2025
Cortical thickness studies in migraine: Current evidence and future directions
Basit Ali Chaudhry, Samaira Younis, Roberta Messina, et al.
The Journal of Headache and Pain
|
December 23, 2025
Hallmarks of primary headache: part 4 - rare headache syndromes
Gabriele Sebastianelli, Woo-Seok Ha, Roberta Messina, et al.
Cephalalgia : an International Journal of Headache
|
November 18, 2024
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society
Francesca Puledda, Irene de Boer, Roberta Messina, et al.
Clinical Kidney Journal
|
October 4, 2021
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination
Elisa Longhitano, Chiara Nardi, Vincenzo Calabrese, et al.
Headache
|
July 26, 2021
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
Piero Barbanti, Cinzia Aurilia, Sabina Cevoli, et al.
BMJ Neurology Open
|
November 10, 2022
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
Marios C Pantzaris, Christos Bakirtzis, Nikolaos Grigoriadis, et al.
The Journal of Headache and Pain
|
February 19, 2026
Premonitory phase in primary headaches: shared and divergent mechanisms in migraine and cluster headache, the Junior Editorial Board Members' vision
Jr-Wei Wu, Linda Al-Hassany, Matteo Castaldo, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 80) with videos related to
Sort By:
Page
of 8
Brain Sciences
|
July 27, 2024
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life Study
Piero Barbanti, Bianca Orlando, Gabriella Egeo, et al.
The Journal of Headache and Pain
|
April 13, 2026
Breaking the medication overuse headache cycle: from nociplastic pain mechanisms to patient-centered interventions - the Junior Editorial Board vision
Roberta Messina, Matteo Castaldo, Woo-Seok Ha, et al.
The Journal of Headache and Pain
|
December 13, 2023
Health equity, care access and quality in headache - part 2
Bianca Raffaelli, Eloísa Rubio-Beltrán, Soo-Jin Cho, et al.
Cephalalgia : an International Journal of Headache
|
June 6, 2025
Cortical thickness studies in migraine: Current evidence and future directions
Basit Ali Chaudhry, Samaira Younis, Roberta Messina, et al.
The Journal of Headache and Pain
|
December 23, 2025
Hallmarks of primary headache: part 4 - rare headache syndromes
Gabriele Sebastianelli, Woo-Seok Ha, Roberta Messina, et al.
Cephalalgia : an International Journal of Headache
|
November 18, 2024
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society
Francesca Puledda, Irene de Boer, Roberta Messina, et al.
Clinical Kidney Journal
|
October 4, 2021
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination
Elisa Longhitano, Chiara Nardi, Vincenzo Calabrese, et al.
Headache
|
July 26, 2021
Long-term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study
Piero Barbanti, Cinzia Aurilia, Sabina Cevoli, et al.
BMJ Neurology Open
|
November 10, 2022
Phase III, randomised, double-blind, placebo-controlled trial of Neuroaspis plp10 as an adjuvant treatment for relapsing multiple sclerosis: the MINERAL Study
Marios C Pantzaris, Christos Bakirtzis, Nikolaos Grigoriadis, et al.
The Journal of Headache and Pain
|
February 19, 2026
Premonitory phase in primary headaches: shared and divergent mechanisms in migraine and cluster headache, the Junior Editorial Board Members' vision
Jr-Wei Wu, Linda Al-Hassany, Matteo Castaldo, et al.
Page
of 8